Han Sang Kim

Honored to also share our recent work on extracellular vesicle proteomics, highlighting tissue- and plasma-derived EV protein signatures for early detection of colon cancer. #EV #Exosome #Proteomics #Cancer #Colon doi.org/10.1002/jev2.7…

Honored to be part of this landmark OrigAMI-1 study in RAS/BRAF wild-type metastatic colorectal cancer. Amivantamab demonstrated promising activity in chemorefractory mCRC, highlighting a potential new strategy for mCRC. #cancer #amivantamab #mCRC ascopubs.org/doi/pdf/10.120…

@CentralParkWMD @MSK_DeptOfMed @NEJM @MSKCancerCenter @oncodaily @brunolarvol @CpcrMsk @OncBrothers @PanCAN @letswinpc @lustgartenfdn Huge congratulations and breakthrough!

1/n Setidegrasib the first-in-human, first-in-class, KRAS G12D-targeted protein degrader #TPD Our KRAS G12D degrader study is now published in the New England Journal of Medicine @NEJM nejm.org/doi/full/10.10… A new way to target KRAS G12D - one of the most common oncogenic drivers across cancers.

@jakelee0711 @CompOncMSK @MSK_DeptOfMed Big congratulations!

Today marks a meaningful milestone -- I am starting as a lab investigator @CompOncMSK and thoracic oncologist @MSK_DeptOfMed, focused on improving treatment through a deep understanding of cancer evolution. I'll soon be looking for fellow travelers on this mission. Stay tuned!

@ASCO #ASCO23 is an amazing annual event for people work in cancer medicine to #meet and #collaborate Almost like annual #Holiday in the first week of June every year~ see you again next year! #ASCO24

@CentralParkWMD Great to meeting with you, Dr. Park!

@HanSangKim5 International and global~! Congrats 🍾🎉 !

Happy to present the collaborative work between Netherlands comprehensive cancer organisation (IKNL) and Yonsei Cancer Center in Korea in Colon cancer. Congrats to Jeongseok (1st author & 4th year medical student!)

.@MSKLibrary feature: Tumour extracellular vesicles & particles induce liver metabolic dysfunction @MengyingHu @DrMicheleCioffi @HanSangKim5 @ChristinBurd @DrJamesLo @geoffrey_pitt @JMHernandez_MD @czambir @JainManeeshjain @DrKelseyKlute dx.doi.org/10.1038/s41586…

It’s an honor to be part of ASCO2022. Yonsei Cancer Center has a platform for large-scale patient data analysis. Please contact me for collaboration in colorectal cancer! #Yonsei #ASCO22 #BigDataAnalysis #CDM #ColonCancer #RectalCancer